Jefferies Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.67M | Buy |
+105,566
| New | +$4.45M | 0.04% | 360 |
|
|
2022
Q1 | – | Sell |
-44,000
| Closed | -$1.34M | – | 1722 |
|
|
2021
Q4 | $1.34M | Sell |
44,000
-137
| -0.3% | -$4.31K | 0.01% | 914 |
|
|
2021
Q3 | $1.48M | Sell |
44,137
-22,567
| -34% | -$850K | 0.01% | 851 |
|
|
2021
Q2 | $2.66M | Buy |
66,704
+46,577
| +231% | +$1.82M | 0.02% | 653 |
|
|
2021
Q1 | $905K | Buy |
20,127
+151
| +0.8% | +$8.42K | 0.01% | 938 |
|
|
2020
Q4 | $1.13M | Buy |
+19,976
| New | +$995K | 0.01% | 901 |
|
|
2020
Q1 | – | Sell |
-8,223
| Closed | -$497K | – | 2339 |
|
|
2019
Q4 | $497K | Sell |
8,223
-22,269
| -73% | -$1.33M | ﹤0.01% | 1810 |
|
|
2019
Q3 | $1.83M | Buy |
30,492
+12,744
| +72% | +$831K | 0.01% | 1143 |
|
|
2019
Q2 | $1.14M | Sell |
17,748
-2,252
| -11% | -$159K | 0.01% | 1217 |
|
|
2019
Q1 | $1.62M | Buy |
20,000
+3,458
| +21% | +$223K | 0.01% | 1017 |
|
|
2018
Q4 | $894K | Buy |
16,542
+12,442
| +303% | +$635K | 0.01% | 1214 |
|
|
2018
Q3 | $211K | Sell |
4,100
-19,459
| -83% | -$914K | ﹤0.01% | 2088 |
|
|
2018
Q2 | $982K | Buy |
+23,559
| New | +$1.04M | 0.01% | 1281 |
|
|
2017
Q4 | – | Sell |
-12,116
| Closed | -$614K | – | 2634 |
|
|
2017
Q3 | $614K | Buy |
12,116
+701
| +6% | +$36.7K | ﹤0.01% | 1524 |
|
|
2017
Q2 | $581K | Sell |
11,415
-12,001
| -51% | -$559K | ﹤0.01% | 1548 |
|
|
2017
Q1 | $941K | Buy |
23,416
+3,416
| +17% | +$153K | 0.01% | 1307 |
|
|
2016
Q4 | $957K | Buy |
20,000
+1,188
| +6% | +$47K | 0.01% | 1302 |
|
|
2016
Q3 | $689K | Buy |
18,812
+3,156
| +20% | +$98.7K | ﹤0.01% | 1468 |
|
|
2016
Q2 | $365K | Sell |
15,656
-1,444
| -8% | -$46.6K | ﹤0.01% | 1572 |
|
|
2016
Q1 | $693K | Sell |
17,100
-15,547
| -48% | -$631K | ﹤0.01% | 1296 |
|
|
2015
Q4 | $2.02M | Buy |
32,647
+17,006
| +109% | +$918K | 0.01% | 854 |
|
|
2015
Q3 | $632K | Sell |
15,641
-15,932
| -50% | -$825K | ﹤0.01% | 1407 |
|
|
2015
Q2 | $1.82M | Buy |
+31,573
| New | +$2.01M | 0.01% | 958 |
|
|
2014
Q3 | – | Sell |
-13,912
| Closed | -$479K | – | 2265 |
|
|
2014
Q2 | $479K | Buy |
13,912
+8,020
| +136% | +$253K | ﹤0.01% | 1262 |
|
|
2014
Q1 | $255K | Buy |
5,892
+5,533
| +1,541% | +$268K | ﹤0.01% | 1601 |
|
|
2013
Q4 | $14K | Buy |
+359
| New | +$12.8K | ﹤0.01% | 1800 |
|
|
2013
Q3 | – | Sell |
-192
| Closed | -$5K | – | 2052 |
|
|
2013
Q2 | $5K | Buy |
+192
| New | +$4.08K | ﹤0.01% | 1777 |
|
Other funds holding IONS
BG
AIM
BI
Jefferies Group's IONS Position: Q3 2022 in Review
Jefferies Group opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2022: 105,566 shares worth $4.67M. The stake represents 0.04% of the portfolio and ranks #360 among its holdings. This is a return to the name: Jefferies Group previously reported a position in IONS as recently as Q4 2021.
Jefferies Group first reported a position in IONS in Q2 2013 and has held it in 27 quarters since. 349 funds tracked by Wall St. Rank hold IONS as of Q3 2022.
- Jefferies Group held 105,566 shares of Ionis Pharmaceuticals worth $4.67M as of Q3 2022.
- Ionis Pharmaceuticals was a new Jefferies Group position in Q3 2022.
- Ionis Pharmaceuticals made up 0.04% of Jefferies Group's portfolio in Q3 2022, its #360 holding.
- Jefferies Group first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
- 349 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.